Adoption and adaptation of CPG and clinical pathways

Systematic reviews

The purpose of systematic reviews is to identify, assess and summarize the results of available individual healthcare studies, in relation to a clinical condition, practice or health technology. This allows key information to be available to decision makers, who must have technical arguments when it comes to using a specific technology or making decisions as vital as including one of them or not in the health benefits plan.

They are also an essential part of building a solid proposition of value and an effective access strategy for all manufacturers or technology providers.

Performing these studies will allow you to take part in the generation of knowledge in our country, which has important consequences for the positioning of your organization.

Our team, under its general director Diego Rosselli (H index of 18 in Google Academic and 11 in Scopus), has extensive experience in publishing this type of studies.

Burden of disease studies

These are valuable tools to assess the impact of a disease on the well-being of a population. By quantifying deaths and loss of general health related to a disease, these evaluations allow the system´s stakeholders to understand the impact of a condition and set priorities for the use of resources. They also help to identify needs and opportunities for the development and implementation of health programs and inclusion of new technologies.

These studies can generate awareness of a certain condition in the country.

Real World Studies

Clinical trials are considered the best tool to demonstrate effectiveness and safety of an intervention. However, there is a growing need for “real world evidence”, since the behavior of a technology in a controlled environment, such as a clinical trial, differs from when there is no strict control and follow-up of the intervention.

In this way, a “real world study” can help you identify and construct propositions of value for the client or other decision-makers.

Our team, under its general director Diego Rosselli (H index of 18 in Google Academic and 11 in Scopus), has extensive experience in publishing this type of studies.

Processing of forms for nominations for the Health Benefits Plan

For the inclusion of new technologies, the Ministry of Health of Colombia requires the methodology stablished by the IETS in order to determine the relevance of including such technologies in the benefits plan. For the nomination process a strict series of steps must be followed which include a effectiveness and safety assessment, economic evaluation and budget impact analysis.

Our team has important experience in the completion of these forms and because of the quality of our work, several of the assessed products have been considered by the ministry of health.

In 2018, only 44 technologies which applied for entrance to the health benefits plan passed the IETS quality filter. Of these, 4 were made by NeuroEconomix. The results of the quality assessments of our work made by the IETS are an endorsement of our quality and differential.

Conferences and workshops- NexTalks

Our team has more than 20 years of experience giving workshops, conferences and symposia on relevant topics in the health sector.

We combine the highest standards of technical knowledge with a clear, easy and useful method of communicating key information to the audience, clear and implementable tools according to their needs.

Please do not hesitate to contact us if you would like to communicate and propose ideas to any stakeholder within the health system.

Contact us at

Evidence-based recommendations

Evidence-based recommendations are systematically developed recommendations, based on the best available evidence and clinical experience, adapted to the local context, to guide health professionals in decision-making in particular clinical circumstances.

They allow providers and insurers to guide their health policies according to the best available technical arguments.

Economic studies

One of the biggest challenges facing decision-makers is to optimize the use of health resources. Because of this, the development of economic studies to evaluate health technologies and programs is becoming increasingly relevant and frequent. These help the decision-maker to establish the relevance of including or not including a technology in the system´s budget. Economic evaluations, and especially cost-effectiveness evaluations, are a fundamental tool in this scenario, as they can show both the potential costs and value of the benefits that a technology or program provides, compared to the standard of care. In this way, they can demonstrate the gains or trade-offs of implementing them or not.

These studies have become important tools to build the proposition of value of your product and have an impact on access. NeuroEconomix has extensive experience in the design and development of these types of projects.

Our team, under its general director Diego Rosselli (H index of 18 in Google Academic and 11 in Scopus), has extensive experience in publishing this type of studies.

Online Solutions

With the support of our strategic partner IdeaXplore, we develop data analysis tools with a detailed and intuitive approach, as well as a user-friendly interface for our clients. IPx is a free-use budget impact calculator that will allow you to make calculations and assessments about the entry of a new technology into the country compared to another.

Processing Invima forms